Monday, 28 September 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Get Alerts
Investor Presentation

Syschem (India) Investor Presentation: Key Takeaways

Syschem reported Q2 FY27 revenue moderation at ₹126 Cr vs ₹126.76 Cr YoY. Despite a net deficit and PBT loss of ₹145 Lakhs, operational stability was maintained through cost discipline.

Syschem (India) Ltd NSE: SYSCHEM Alert sent Investor presentation
Highlights
MarginsEBITDA moderation and margins compressed by forex volatility
Demand visibilityCautious demand due to global economic uncertainties
Management confidenceModerate

Growth

Revenue stable YoY at ₹126 Cr; EBITDA plunged to ₹38 Lakhs from ₹247 Lakhs YoY; PAT turned negative.

Outlook

Capacity expansion for Amoxicillin, Cloxacillin, and Dicloxacillin plants; pursuing WHO-GMP certification for global market growth.

Risks

Foreign exchange fluctuations and global financial market volatility impacted PBT significantly during the quarter.

Source

Investor Presentation filed with BSE, NSE: SYSCHEM. Summary written with AI assistance from the document.

Read the document ↗

Syschem (India) Ltd: key numbers

Share price
₹37.94
Market cap
₹186.0 Cr
Revenue (annual)
₹654.6 Cr
Net profit (annual)
₹10.93 Cr
P/E (TTM)
30.3×Sector 50.4×
Promoter holding
63.38%+2.52% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Syschem (India) Ltd

All →
10:56 IST BSE
Annual General Meeting

Syschem (India) Annual General Meeting

Syschem (India) Limited issued its 33rd AGM notice for September 30, 2026. Key agendas include approving material related-party transactions and appointing statutory auditors.

Read the filing ↗
10:47 IST BSE
Annual Report

Syschem (India) Annual Report

Syschem (India) Limited has filed its 33rd Annual Report for FY 2025-26. The company convened its Annual General Meeting for September 30, 2026.

Read the filing ↗